These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 18427604)

  • 1. Association between thyroid-stimulating immunoglobulin levels and ocular findings in pediatric patients with Graves disease.
    Acuna OM; Athannassaki I; Paysse EA
    Trans Am Ophthalmol Soc; 2007; 105():146-50; discussion 150-1. PubMed ID: 18427604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy.
    Gerding MN; van der Meer JW; Broenink M; Bakker O; Wiersinga WM; Prummel MF
    Clin Endocrinol (Oxf); 2000 Mar; 52(3):267-71. PubMed ID: 10718823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
    Woo YJ; Jang SY; Lim TH; Yoon JS
    Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods.
    Morris JC; Hay ID; Nelson RE; Jiang NS
    Mayo Clin Proc; 1988 Jul; 63(7):707-17. PubMed ID: 2898572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assays for thyroid-stimulating antibodies and thyrotropin-binding inhibitory immunoglobulins in children with Graves' disease.
    Shibayama K; Ohyama Y; Yokota Y; Ohtsu S; Takubo N; Matsuura N
    Endocr J; 2005 Oct; 52(5):505-10. PubMed ID: 16284425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of clinical course with thyroid-stimulating immunoglobulin in Graves' ophthalmopathy in Mongolians.
    Bayarmunkh O; Ganbold C; Das S; Davaatseren U; Minjuurdorj NE; Jav S
    PLoS One; 2022; 17(11):e0277055. PubMed ID: 36395261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy.
    Khoo DH; Ho SC; Seah LL; Fong KS; Tai ES; Chee SP; Eng PH; Aw SE; Fok AC
    Thyroid; 1999 Dec; 9(12):1175-80. PubMed ID: 10646655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
    Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
    Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy.
    Lytton SD; Ponto KA; Kanitz M; Matheis N; Kohn LD; Kahaly GJ
    J Clin Endocrinol Metab; 2010 May; 95(5):2123-31. PubMed ID: 20237164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of TSH-receptor antibody levels in predicting disease course in Graves' orbitopathy: comparison of the third-generation TBII assay and Mc4-TSI bioassay.
    Jang SY; Shin DY; Lee EJ; Lee SY; Yoon JS
    Eye (Lond); 2013 Aug; 27(8):964-71. PubMed ID: 23743527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methimazole with or without exogenous L-thyroxine on serum concentrations of thyrotropin (TSH) receptor antibodies in patients with Graves' disease.
    Rittmaster RS; Zwicker H; Abbott EC; Douglas R; Givner ML; Gupta MK; Lehmann L; Reddy S; Salisbury SR; Shlossberg AH; Tan MH; York SE
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3283-8. PubMed ID: 8784084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of thyroid-stimulating immunoglobulins in graves' ophthalmopathy.
    Ponto KA; Kanitz M; Olivo PD; Pitz S; Pfeiffer N; Kahaly GJ
    Ophthalmology; 2011 Nov; 118(11):2279-85. PubMed ID: 21684605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin in Graves' disease: a more reliable index of circulating thyroid-stimulating immunoglobulin level than thyroid function?
    Kabadi UM; Premachandra BN
    Endocr Pract; 2007 Oct; 13(6):615-9. PubMed ID: 17954417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between TSH receptor antibody assays and clinical manifestations of Graves' orbitopathy.
    Jang SY; Shin DY; Lee EJ; Choi YJ; Lee SY; Yoon JS
    Yonsei Med J; 2013 Jul; 54(4):1033-9. PubMed ID: 23709442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison Between Thyroid Stimulating Immunoglobulin and TSH-Receptor Antibodies in the Management of Graves' Orbitopathy.
    Khamisi S; Lundqvist M; Engström BE; Larsson A; Karlsson FA; Ljunggren Ö
    Exp Clin Endocrinol Diabetes; 2023 Apr; 131(4):236-241. PubMed ID: 36706788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum immunoglobulin G4 levels and Graves' disease phenotype.
    Martin CS; Sirbu AE; Betivoiu MA; Florea S; Barbu CG; Fica SV
    Endocrine; 2017 Feb; 55(2):478-484. PubMed ID: 27819113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated Serum Tetrac in Graves Disease: Potential Pathogenic Role in Thyroid-Associated Ophthalmopathy.
    Fernando R; Placzek E; Reese EA; Placzek AT; Schwartz S; Trierweiler A; Niziol LM; Raychaudhuri N; Atkins S; Scanlan TS; Smith TJ
    J Clin Endocrinol Metab; 2017 Mar; 102(3):776-785. PubMed ID: 27768856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting the Development of Orbitopathy in Graves Thyroidopathy Patients: The Potential Role of TSI Testing.
    Takakura A; Kirkeby K; Earle K; Silkiss RZ
    Ophthalmic Plast Reconstr Surg; 2015; 31(5):369-72. PubMed ID: 25585304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional TSH receptor antibodies in children with autoimmune thyroid diseases.
    Stożek K; Bossowski A; Ziora K; Bossowska A; Mrugacz M; Noczyńska A; Walczak M; Petriczko E; Pyrżak B; Kucharska A; Szalecki M; Diana T; Kahaly GJ
    Autoimmunity; 2018 Mar; 51(2):62-68. PubMed ID: 29372654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.